K-Bio Lab Hub Project Promotion Group and Korea Polar Research Institute to Support Bio Startups

Support from Discovery of Candidate Substances to Commercialization
"Establishing a Specialized Support System and Infrastructure"

The K-Bio Lab Hub Project Promotion Group of the Small and Medium Business Technology Information Promotion Agency announced on the 20th that it has signed a business agreement with the Korea Polar Research Institute, an affiliate of the Korea Institute of Ocean Science and Technology.

This agreement was made to strengthen the development and support of domestic pharmaceutical and bio startups by establishing a specialized support system that covers everything from the discovery of candidate substances to commercialization, and to lay the foundation for a research cooperation system between the two organizations.

At the business agreement ceremony held on the 19th at the Korea Polar Research Institute in Songpa-gu, Seoul, Han Inseok, Head of the K-Bio Lab Hub Project Promotion Group (left), and Shin Hyungchul, Director of the Korea Polar Research Institute, are posing for a commemorative photo. Photo by Small and Medium Business Technology Information Promotion Agency

The main points of the agreement include: ▲ joint use of bio research facilities and infrastructure; ▲ joint research and cooperation for bio technology development and commercialization; and ▲ support for expanding the domestic and international bioindustry ecosystem and global cooperation networking.

The Promotion Group expects that, through this agreement, the cutting-edge research infrastructure and expertise of the Korea Polar Research Institute will be utilized for the technology development and commercialization of innovative startups within the K-Bio Lab Hub, thereby further strengthening cooperation between the two organizations.

Inseok Han, Head of the Promotion Group, stated, "Through this business agreement, we will further solidify the specialized support system and infrastructure that enable startups to grow," adding, "We will continue to seek ways to support domestic pharmaceutical and bio startups across various fields in the future."

This content was produced with the assistance of AI translation services.